
A medical worker hands an aerosolized COVID vaccine developed by Chinese biopharmaceutical firm CanSino Biologics Inc. in Shanghai on Oct. 26.
13:05 JST, November 8, 2022
BEIJING (AP) — The Chinese city of Shanghai started administering an inhalable COVID-19 vaccine on Oct. 26 in what appears to be a world first.
The vaccine, a mist that is sucked in through the mouth, is being offered for free as a booster dose for previously vaccinated people, according to an announcement on an official city social media account.
Scientists hope that such “needle-free” vaccines will make vaccination more accessible in countries with fragile health systems because they are easier to administer. They also may persuade people who don’t like getting a shot in the arm to get inoculated.
China wants more people to get booster shots before it relaxes strict pandemic restrictions that are holding back the economy and are increasingly out of sync with the rest of the world. As of mid-October, 90% of Chinese were fully vaccinated and 57% had received a booster shot.
A video posted by an online Chinese state media outlet showed people at a community health center sticking the short nozzle of a translucent white cup into their mouths. The accompanying text said that after slowly inhaling, people hold their breath for five seconds, with the entire procedure completed in 20 seconds. “It was like drinking a cup of milk tea,” one Shanghai resident said in the video. “When I breathed it in, it tasted a bit sweet.”
The effectiveness of non-needle vaccines has not been fully explored. Chinese regulators approved the inhalable one in September, but only as a booster shot after studies showed it triggered an immune system response in people who had previously received two shots of a different Chinese vaccine.
A vaccine taken as mist could fend off the virus before it reaches the rest of the respiratory system, though that would depend in part on the size of the droplets, one expert said.
Larger droplets would train defenses in parts of the mouth and throat, while smaller ones would travel further into the body, said Dr. Vineeta Bal, an immunologist in India.
The inhalable vaccine was developed by Chinese biopharmaceutical company CanSino Biologics Inc. as an aerosol version of the company’s one-shot adenovirus vaccine, which uses a relatively harmless cold virus.
The traditional one-shot vaccine has been approved for use in more than 10 markets including China, Hungary, Pakistan, Malaysia, Argentina and Mexico.
"World" POPULAR ARTICLE
-
Former North Korean Agent Says Still Many Spies in South Korea Looking to Strain Relations with Japan
-
Japanese Firefighter Who Worked in Quake-Hit Myanmar Hopes Others Will Help in Intl Relief Efforts
-
Glass Stresses Need for U.S.-Japan Alliance to Invest, Innovate; Commends Japan for Taking Leading Role in Region
-
Head of Interim Bangladesh Govt Yunus: Election to Be Held Between Dec. 2025 and June 2026; Cotton, LNG Eyed as Bargaining Chips in Bangladesh-U.S. Trade Talks
-
Headaches and Cigarettes: Conviction of Pyongyang Spies Reveals Their Playbook of Codes, Signals
JN ACCESS RANKING
-
Toyoda to Become Automobile Business Association of Japan Chairman; to Help Guide U.S. Tariff-Affected Industriessns
-
Advance Payments for 2025 Rice Foretell Rising Prices; Big Buyers Moving Early; Farmers Spurred to Grow More
-
Visitors to Japan Hit Single-Month Record High in April
-
Japanese Researchers Develop ‘Transparent Paper’ as Alternative to Plastics; New Material Is Biodegradable, Can Be Produced with Low Carbon Emissions
-
Japan to Introduce Car Fuel with Up to 10% Biofuels from Fiscal 2028; Limited Rollout Expected at Areas with Refineries